|
⚲
|
| Keyboard |
| Hatteras Venture Partners I LP
✚
|
|
|---|---|
| CIK # | 0001756231 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001756231] | |
| 4 | [0001756231] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 1,683,420 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Buy | 150,000 | $5.00 | 750,000 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 52,690 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 266,481 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Buy | 137,513 | $5.00 | 687,565 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 150,612 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Buy | 12,487 | $5.00 | 62,435 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 4,846 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Warrants to Purchase Series C-1 Preferred Stock · derivative
|
2018-10-22 | Option exercise | 41,414 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series D Preferred Stock · derivative
|
2018-10-22 | Conversion | 226,061 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series D Preferred Stock · derivative
|
2018-10-22 | Conversion | 24,709 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series D Preferred Stock · derivative
|
2018-10-22 | Conversion | 272,107 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Conversion | 40,420 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Conversion | 13,558 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Conversion | 149,320 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Conversion | 94,874 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Conversion | 1,044,764 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series AA Preferred Stock · derivative
|
2018-10-22 | Conversion | 13,609 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series AA Preferred Stock · derivative
|
2018-10-22 | Conversion | 174,699 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series 1 Preferred Stock · derivative
|
2018-10-22 | Conversion | 4,846 | $0.00 | |
| showing 20 of 37 most recent transactions | |||||